The SLAM family of immune-cell receptors

Current Opinion in Immunology

Volumn 15, Issue 3, 2003, Pages 277-285

  Veillette, André ^a,b,c   Latour, Sylvain ^d  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CELL RECEPTOR; FLIL ACTIVATED TRANSCRIPT 2; MUTANT PROTEIN; PROTEIN; RECEPTOR SUBTYPE; SIGNALLING LYMPHOCYTE ACTIVATION MOLECULE PROTEIN; UNCLASSIFIED DRUG;

BINDING AFFINITY; CELL FUNCTION; CELL SPECIFICITY; CELL TYPE; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; NONHUMAN; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 0038392948     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00041-4     Document Type: Review

References (50)

1. Miceli M.C., Parnes J.R. The roles of CD4 and CD8 in T cell activation. Semin. Immunol. 3:1991;133-141.
2. Sharpe A.H., Freeman G.J. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:2002;116-126.
3. Tangye S.G., Phillips J.H., Lanier L.L. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells. Semin. Immunol. 12:2000;149-157.
4. Morra M., Howie D., Grande M.S., Sayos J., Wang N., Wu C., Engel P., Terhorst C. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol. 19:2001;657-682.
5. Veillette A: The SAP family: a new class of adaptor-like molecules that regulates immune cell functions. Sci STKE 2002:E8.
6. de la Fuente M.A., Tovar V., Villamor N., Zapater N., Pizcueta P., Campo E., Bosch J., Engel P. Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. Blood. 97:2001;3513-3520.
7. Bottino C., Falco M., Parolini S., Marcenaro E., Augugliaro R., Sivori S., Landi E., Biassoni R., Notarangelo L.D., Moretta L., Moretta A. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:2001;235-246 This paper describes the cloning and characterisation of NTB-A, a novel SLAM-related receptor that interacts with SAP. NTB-A is expressed in NK cells, T cells and B cells. In NK cells, engagement of NTB-A by antibodies was shown to trigger cell cytotoxicity. This function was dependent on SAP. Intriguingly, in the absence of SAP, NTB-A engagement provoked an inhibition of NK cell-mediated cytotoxicity. Alterations in the function of NTB-A may account for part of the inability of XLP patients to mount appropriate cytotoxic responses against EBV-infected cells.
8. Bouchon A., Cella M., Grierson H.L., Cohen J.I., Colonna M. Cutting edge: activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol. 167:2001;5517-5521 This manuscript reports on the cloning and characterisation of CRACC, a novel receptor belonging to the SLAM family, which is expressed in NK cells, DCs, T cells and B cells. Interestingly, CRACC was shown to lack detectable association with SAP. In NK cells, CRACC stimulation by antibodies resulted in NK cell-mediated cytotoxicity. In NK cells from XLP patients, this stimulatory function was preserved, supporting the idea that CRACC does not associate with SAP.
9. Mavaddat N., Mason D.W., Atkinson P.D., Evans E.J., Gilbert R.J., Stuart D.I., Fennelly J.A., Barclay A.N., Davis S.J., Brown M.H. Signalling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J. Biol. Chem. 275:2000;28100-28109.
10. Martin M., Romero X., de la Fuente M.A., Tovar V., Zapater N., Esplugues E., Pizcueta P., Bosch J., Engel P. CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1. J. Immunol. 167:2001;3668-3676.
11. Kumaresan P., Lai W., Chuang S., Bennett M., Mathew P. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol. Immunol. 39:2002;1-8.
12. Latour S., Gish G., Helgason C.D., Humphries R.K., Pawson T., Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat. Immunol. 2:2001;681-690 The authors of this report analysed the physical and functional interactions between SLAM and SAP using a model T-cell line. SLAM-SAP interaction was shown to result in an intracellular tyrosine phosphorylation signal that involved SLAM itself, the 5′ inositol phosphatase SHIP-1, the adaptors Dok-1, Dok-2 and Shc, as well as the Ras GTPase-activating protein Ras-GAP. This signal was coupled to a selective inhibition of IFN-γ production by activated T cells. Additional studies showed that SAP was required for SLAM signalling as a result of its capacity to promote the selective recruitment and activation of FynT, a Src-related PTK.
13. Tatsuo H., Ono N., Tanaka K., Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature. 406:2000;893-897.
14. Hsu E.C., Iorio C., Sarangi F., Khine A.A., Richardson C.D. CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology. 279:2001;9-21 Together with [13], this manuscript demonstrates that SLAM is the lymphoid-specific receptor for measles virus in humans.
15. Morra M., Lu J., Poy F., Martin M., Sayos J., Calpe S., Gullo C., Howie D., Rietdijk S., Thompson A.et al. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J. 20:2001;5840-5852.
16. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G.et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462-469.
17. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E.et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad Sci. USA. 95:1998;13765-13770.
18. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P.et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:1998;129-135.
19. Purtilo D.T., Cassel C.K., Yang J.P., Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 1:1975;935-940.
20. Seemayer T.A., Gross T.G., Egeler R.M., Pirruccello S.J., Davis J.R., Kelly C.M., Okano M., Lanyi A., Sumegi J. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res. 38:1995;471-478.
21. ••].
22. ••] show that mice with a disrupted sap gene have aberrant immune responses when challenged with LCMV, Toxoplasma gondii or Leishmania major. These altered responses were characterised by increased IFN-γ production and decreased IL-4 production. In vitro studies also indicated that T lymphocytes from SAP-deficient mice failed to differentiate into Th2 cells.
23. Crotty S., Kersh E.N., Cannons J., Schwartzberg P.L., Ahmed R. SAP is required for the generation of long term humoral immunity. Nature. 421:2003;282-287 This paper demonstrates that the virus-induced generation of memory B cells and germinal centres is defective in SAP-deficient mice. This is seemingly caused by an intrinsic T-cell help defect.
24. Nakajima H., Colonna M. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. Hum. Immunol. 61:2000;39-43.
25. Parolini S., Bottino C., Falco M., Augugliaro R., Giliani S., Franceschini R., Ochs H.D., Wolf H., Bonnefoy J.Y., Biassoni R.et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192:2000;337-346.
26. Tangye S.G., Phillips J.H., Lanier L.L., Nichols K.E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165:2000;2932-2936.
27. Nakajima H., Cella M., Bouchon A., Grierson H.L., Lewis J., Duckett C.S., Cohen J.I., Colonna M. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30:2000;3309-3318.
28. Poy F., Yaffe M.B., Sayos J., Saxena K., Morra M., Sumegi J., Cantley L.C., Terhorst C., Eck M.J. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell. 4:1999;555-561.
29. Li S.C., Gish G., Yang D., Coffey A.J., Forman-Kay J.D., Ernberg I., Kay L.E., Pawson T. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. Curr. Biol. 9:1999;1355-1362.
30. Hwang P.M., Li C., Morra M., Lillywhite J., Muhandiram D.R., Gertler F., Terhorst C., Kay L.E., Pawson T., Forman-Kay J.D., Li S.C. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome. EMBO J. 21:2002;314-323 Together with [28,29], this paper describes the analysis of the mode of interaction of the SAP or EAT-2 SH2 domains with SRRs by crystallography, nuclear magnetic resonance and random peptide library screening studies. These interactions were shown to be mediated by the tyrosine-based motif TIYxxV/I, located in the cytoplasmic domain of SRRs. Remarkably, the binding of the SAP/EAT-2 SH2 domain to this motif involved a third point of contact between the SH2 domain and residues located amino-terminal to the phosphotyrosine, resulting in a 'three-pronged' interaction. In the case of SLAM, the interaction with the SAP SH2 domain did not require phosphorylation of the tyrosine, but was strengthened by phosphorylation.
31. Latour S., Roncagalli R., Chen R., Bakinowski M., Shi X., Schwartzberg P.L., Davidson D., Veillette A. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat. Cell Biol. 5:2003;149-154 This manuscript describes the mechanism by which SAP promotes the recruitment and activation of FynT in the SLAM-SAP signalling pathway. It was shown that SAP interacts directly with the SH3 domain of FynT. This interaction involves a nonproline-based motif located in the SH2 domain of SAP that is independent of the phosphotyrosine-binding pocket. Mutation of arginine residue 78 of SAP abolished the capacity of SAP to bind to FynT, as well as SLAM-induced intracellular protein tyrosine phosphorylation and modulation of cytokine production in T cells.
32. Chan B., Lanyi A., Song H.K., Griesbach J., Simarro-Grande M., Poy F., Howie D., Sumegi J., Terhorst C., Eck M.J. SAP couples Fyn to SLAM immune receptors. Nat. Cell Biol. 5:2003;155-160 This paper reports on the crystal structure of a complex between a SLAM peptide, the SAP SH2 domain and the FynT SH3 domain.
33. Cocks B.G., Chang C.C., Carballido J.M., Yssel H., de Vries J.E., Aversa G. A novel receptor involved in T-cell activation. Nature. 376:1995;260-263.
34. Castro A.G., Hauser T.M., Cocks B.G., Abrams J., Zurawski S., Churakova T., Zonin F., Robinson D., Tangye S.G., Aversa G.et al. Molecular and functional characterization of mouse signalling lymphocytic activation molecule (SLAM): differential expression and responsiveness in Th1 and Th2 cells. J. Immunol. 163:1999;5860-5870.
35. Henning G., Kraft M.S., Derfuss T., Pirzer R., Saint-Basile G., Aversa G., Fleckenstein B., Meinl E. Signalling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity. Eur. J. Immunol. 31:2001;2741-2750.
36. Punnonen J., Cocks B.G., Carballido J.M., Bennett B., Peterson D., Aversa G., de Vries J.E. Soluble and membrane-bound forms of signalling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185:1997;993-1004.
37. Kruse M., Meinl E., Henning G., Kuhnt C., Berchtold S., Berger T., Schuler G., Steinkasserer A. Signalling lymphocytic activation molecule is expressed on mature CD83(+) dendritic cells and is up-regulated by IL-1beta. J. Immunol. 167:2001;1989-1995.
38. Bleharski J.R., Niazi K.R., Sieling P.A., Cheng G., Modlin R.L. Signalling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J. Immunol. 167:2001;3174-3181.
39. Moretta A., Bottino C., Vitale M., Pende D., Cantoni C., Mingari M.C., Biassoni R., Moretta L. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:2001;197-223.
40. Watzl C., Stebbins C.C., Long E.O. NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165:2000;3545-3548.
41. Valiante N.M., Trinchieri G. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178:1993;1397-1406.
42. Bottino C., Augugliaro R., Castriconi R., Nanni M., Biassoni R., Moretta L., Moretta A. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol. 30:2000;3718-3722.
43. Klem J., Verrett P.C., Kumar V., Schatzle J.D. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol. 169:2002;55-62.
44. Benoit L., Wang X., Pabst H.F., Dutz J., Tan R. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165:2000;3549-3553.
45. Garni-Wagner B.A., Purohit A., Mathew P.A., Bennett M., Kumar V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol. 151:1993;60-70.
46. Kambayashi T., Assarsson E., Chambers B.J., Ljunggren H.G. Cutting edge: Regulation of CD8(+) T cell proliferation by 2B4/CD48 interactions. J. Immunol. 167:2001;6706-6710.
47. de la Fuente M.A., Pizcueta P., Nadal M., Bosch J., Engel P. CD84 leukocyte antigen is a new member of the Ig superfamily. Blood. 90:1997;2398-2405.
48. Sayos J., Martin M., Chen A., Simarro M., Howie D., Morra M., Engel P., Terhorst C. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood. 97:2001;3867-3874.
49. Tangye S.G., van de Weerdt B.C., Avery D.T., Hodgkin P.D. CD84 is up-regulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2. Eur. J. Immunol. 32:2002;1640-1649.
50. Tovar V., Del Valle J., Zapater N., Martin M., Romero X., Pizcueta P., Bosch J., Terhorst C., Engel P. Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors. Immunogenetics. 54:2002;394-402.